Gates Research Institute to Develop Glaxo’s Promising TB Vaccine

January 29, 2020

GlaxoSmithKline Plc licensed a promising vaccine against tuberculosis to the Bill & Melinda Gates Medical Research Institute in a move the drugmaker said will help bring prevention of the deadly disease to poor countries.

Related Stories